13FULTRAGENYX PHARMACEUTICAL IN (RARE)
4 tracked managers currently hold RARE on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $120.9M | 0.1 % | 0.0 % | 3,621,200 | +1,415,380 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $57.8M | 0.0 % | 0.0 % | 1,730,193 | +469,175 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $25.4M | 0.0 % | 0.0 % | 760,825 | -1,011,359 |
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $7.0M | 0.0 % | 0.0 % | 210,531 | -1,904,960 |